Wegovy half dose clicks: separating myth from fact

The misconception: that you can count clicks to get a partial dose

It is easy to see where this idea comes from. Wegovy's injection pen makes an audible click when the plunger is depressed, and patients who have used insulin pens with adjustable dials sometimes assume a similar logic applies here. It does not. Wegovy pens are single-strength, pre-loaded devices: pressing the button fires the complete contents of that pen's cartridge into the injection site. There is no mid-press stopping point that delivers half the medicine and reserves the rest for another day.

Attempting to stop an injection partway through also risks inconsistent delivery (some of the dose may pool at the skin surface rather than reach the subcutaneous tissue) and once a pen has been activated, the remaining contents cannot reliably be used again. The NHS semaglutide medicines page is clear that each pen is for one person and should not be shared or re-used.

The phrase "half dose clicks" has circulated on forums as a workaround for nausea in the early weeks. The clinical answer to that problem is different, and more straightforward, than it sounds.

What the titration schedule is actually designed to do

Semaglutide's dose ladder (starting at 0.25 mg, stepping through 0.5 mg, 1.0 mg, 1.7 mg, and up to the 2.4 mg maintenance dose, with a further 7.2 mg option approved by the MHRA in April 2026) is not arbitrary. Each rung is a deliberate pause, usually around four weeks, giving your gut-hormone pathways time to adjust before the next increase. That is why the starting strength exists: its job is adjustment, not weight loss. The nausea, bloating, or indigestion that sometimes appears when a new pen arrives is the system working as expected, not a signal to improvise.

If side effects are significant, the licensed and clinically supported response is to stay on the current dose for longer, or (in discussion with your prescriber) to delay the step up. That flexibility is built into the SmPC precisely because individual tolerance varies. You can read more about how the full dose range is structured on the Wegovy doses overview.

What is not built into the treatment plan is a self-directed partial dose delivered by stopping a pen mid-click. A prescriber reviewing your case can document a formal titration pause; a half-pressed pen cannot.

Clicks, the 2.4 mg pen, and what those numbers refer to in practice

Much of the online confusion conflates two different uses of the word "clicks". Some patients use it loosely to mean the pen's activation mechanism. Others have seen references to specific click counts in the context of older multi-dose pen formats used in some markets. In the UK, Wegovy is supplied as pre-filled, single-dose injection pens. The click you hear is the plunger completing its travel, confirmation the full dose has been given, not a unit you can subdivide.

If you are on the 1.0 mg pen and wondering how its delivery compares with the 1.7 mg pen, the detail on the 1.0 mg Wegovy pen and the separate 1.7 mg pen guidance cover the mechanism for each strength. The short version: neither pen has a user-adjustable dial. Store whichever pen you are using in the fridge (ideally somewhere stable like the main shelf rather than the door, where temperature fluctuates) and follow the timings in your Patient Information Leaflet exactly.

For questions about the 2.4 mg maintenance pen specifically, the 2.4 mg pen and its delivery mechanism is covered in detail separately.

When to act, and who to talk to

Side effects that feel unmanageable are worth raising promptly. Nausea and digestive discomfort are the most common, particularly after a dose increase, and they are usually temporary, but "usually temporary" is not the same as "ignore it". If vomiting is making it hard to stay hydrated, that warrants contact with a clinician the same day. Severe or persistent stomach pain that radiates to the back needs urgent assessment, given the MHRA's guidance on pancreatitis risk with GLP-1 medicines.

Self-adjusting your Wegovy dose by mechanical means is not the safe middle ground it might appear. The right route is a prescriber conversation: they can slow your titration formally, review whether Wegovy is still the right choice, or check whether something else is contributing to your symptoms. You can also explore whether halving your Wegovy dose is ever a clinical option, which covers the question from a prescriber's perspective rather than a pen-mechanics one.

For a broader view of the treatment (how it works, what results clinical trials showed, and how private and NHS access compare) the Wegovy treatment guide brings it together in one place. And if cost is part of why you are searching for workarounds, the Wegovy cost breakdown is worth reading before drawing conclusions.

If you are not yet on treatment and want clinical input on which starting point makes sense for you, our prescribers review consultations the same day, a real clinician reads your answers, not automated software. Start your free consultation to find out whether Wegovy is clinically suitable for you.